• No results found

Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme

N/A
N/A
Protected

Academic year: 2020

Share "Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme"

Copied!
15
0
0

Loading.... (view fulltext now)

Full text

Figure

Fig. 1 Ongoing challenges and unmet needs in the management of pulmonary fibrosis, and timeline of the nintedanib clinical programme to date
Fig. 2 Rate of change in FVC over 12 weeks in the INMARK and INPULSIS trials. a [43],; b [2, 41], and data on file (Boehringer Ingelheim).
Table 2 Comorbidities and concomitant medication use at baseline in real-world IPF populations receiving nintedanib Study author, year

References

Related documents

Consistently, both flow cytometry assay and TUNEL assays showed that ei- ther knockdown of Fas or treatment with Z-VAD-FMK could remarkably suppress cell apoptosis induced by

Both groups participated in two sessions at least 3 days apart (median time between session: 27 days for stroke-to-control, 28 days for control-to-stroke) and re- ceived the same

In conclusion, the present study has revealed that sper- midine treatment of BV2 microglial cells inhibited LPS- induced NO and PGE 2 production by suppressing iNOS and COX-2 mRNA

Genes were identified using Prodigal [31] as part of the Oak Ridge National Laboratory genome an- notation pipeline, followed by a round of manual curation using the JGI

Sample and study design: 9,284 adult diabetes Type 2 patients registered to the Diabetes registry project, 2,244 patients with duration of diabetes more than 15 years and 7,040

A high cholesterol diet is associated with decrease in both systolic and diastolic cardiac function in rabbits as meas- ured by TDI, while ezetimibe is protective by its capacity

In contrast to accessibility of general obstetric units as descried above, accessibility of specialized obstetric units was significantly higher in England compared to Ger- many

ASCs: Adipose tissue-derived MSCs; CFSE: Carboxy fluorescein diacetate succinimidyl ester; ECM: Extra cellular matrix; EVs: Extracellular vesicles; FLSs: Fibroblast-like